Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05374421 · ClinicalTrials.gov registry record · NA
Efficacy of the Erchonia Corporation THL™ for Providing Relief of Tinnitus Symptoms
A NA study, sponsored by Erchonia Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05374421 is a NA study that was terminated before completion, run by Erchonia Corporation. The registered enrollment target is 23 participants.
The verdict
NCT05374421, a NA study, was terminated before completion, sponsored by Erchonia Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® THL™, manufactured by Erchonia Corporation (the Company), for prescription home use in providing relief of tinnitus symptoms when used by individuals in their own homes.
Interventions
- DEVICE Placebo Laser
- DEVICE Erchonia® THL™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-05-10 |
| Est. Completion | 2022-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05374421
The ClinicalTrials.gov registry entry for NCT05374421 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Laser is the first listed.
NCT05374421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05374421 about?
NCT05374421 is a clinical study titled "Efficacy of the Erchonia Corporation THL™ for Providing Relief of Tinnitus Symptoms". The purpose of this clinical study is to determine the effectiveness of the Erchonia® THL™, manufactured by Erchonia Corporation (the Company), for prescription home use in providing relief of tinnitus symptoms when used by individuals in their own homes.
What is the current status of trial NCT05374421?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2022-05-10. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT05374421?
The interventions under investigation include: Placebo Laser (DEVICE), Erchonia® THL™ (DEVICE).
Who is sponsoring clinical trial NCT05374421?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.